A new type of antibiotic uses DNA to fight a common deadly microbe, Clostridium difficile. These new drugs are inexpensive and adaptable and can be modified to target any bacterium, lowering the chance of drug resistance.
L’expertise universitaire, l’exigence journalistique
Articles sur C. difficile
Ensemble des articles
Antibiotic resistance is a major health threat that causes almost 700,000 deaths a year, and its toll is expected to grow. Here are some things you can do to offer your own resistance.
The modern lifestyle, particularly diet and hygiene changes, have altered our relationship with our microbes. But can we restore it?
Going to the hospital can save your life, but it is not without risks. Patients can be exposed to dangerous infections while receiving treatment. In the United States, health care-associated infections…
Bacteria-eating viruses that kill the hospital superbug C. difficile have been isolated by scientists. The use of these kinds of viruses, known as phages, to tackle bacterial infection was employed before…
Les contributeurs les plus fréquents
-
Reader in Biology, University of Leicester
-
Professor, ARC Laureate Fellow & Academic Director, The Charles Perkins Centre, University of Sydney
-
Clinical Associate Professor of Pharmacy, The Ohio State University
-
Senior Research Fellow in Physiology, School Medical Sciences, University of Sydney
-
Associate Professor of Pharmacology, Penn State
-
Associate Professor, University of Sydney
-
Johann Friedrich Miescher Regents Professor in Molecular Biology, The University of Texas at Austin
-
Associate Professor of Surgery, University of Arizona
-
Professor of Molecular Microbiology, UCL
-
Assistant Professor of Pharmacy, The University of Texas at Austin
